tiprankstipranks
Izotropic Seeks FDA Feedback for Breast Cancer Imaging Device
Company Announcements

Izotropic Seeks FDA Feedback for Breast Cancer Imaging Device

Story Highlights

Invest with Confidence:

An update from Izotropic ( (TSE:IZO) ) is now available.

Izotropic announced the filing of a pre-submission with the U.S. FDA for the approval of its IzoView Breast CT Imaging System, designed for breast cancer screening in women with dense breast tissue. This advancement responds to a significant need for high-resolution imaging modalities that can improve early detection rates, potentially expanding the market size for IzoView scans by 800%, thus enhancing Izotropic’s market positioning and addressing critical healthcare demands.

More about Izotropic

Izotropic Corporation is a medical device company focused on developing imaging-based products using innovative and emerging technologies for the accurate screening, diagnosis, and treatment of breast cancers.

YTD Price Performance: 150.0%

Average Trading Volume: 76,117

Technical Sentiment Consensus Rating: Sell

Current Market Cap: $6.52M

Find detailed analytics on IZO stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App

Latest News Feed

More Articles